<p><span style="font-size: small"><b>Oncogenomics</b> is <span style="color: #000000">relatively new sub-field of genomics, which applies high throughput technologies to characterize genes associated with cancer. </span></span></p><p><span style="font-size: small"><span style="color: #000000">Oncogenomics is synonymous with &quot;cancer genomics&quot;. Cancer is a genetic disease caused by accumulation of mutations to DNA leading to unrestrained cell proliferation and neoplasm formation. The goal of oncogenomics is to identify new oncogenes or tumor suppressor genes that may provide new insights into cancer diagnosis, predicting clinical outcome of cancers, and new targets for cancer therapies. The success of targeted cancer therapies such as Gleevec, Herceptin, and Avastin raised the hope for oncogenomics to elucidate new targets for cancer treatment<sup id="cite_ref-Strausberg2004_0-0" class="reference">[1]</sup>.</span></span></p>